Site icon Hot Paths

FDA turns to AI to accelerate drug reviews (MSFT:NASDAQ)

Press Room
May 08, 2025 2:53 PM ETMicrosoft Corporation (MSFT) Stock, PFE Stock, MRK Stock, JNJ StockAMGN, BIIB, GILD, GSK, BMY, ABT, NVO, LLY, SNY, AZN, SNYNF, ABBV, MRNABy: Dulan Lokuwithana, SA News Editor
US Food and Drug Administration (FDA)

The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) across all FDA centers by June 30 in a bid to speed up the review process of new drugs.

The decision comes

Exit mobile version